Is Lyrica (pregabalin) a nonsteroidal anti-inflammatory drug (NSAID)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Is Lyrica (Pregabalin) an NSAID?

No, Lyrica (pregabalin) is not a nonsteroidal anti-inflammatory drug (NSAID). Pregabalin is an anticonvulsant medication that works by inhibiting presynaptic excitatory neurotransmitter release by blocking α2δ calcium channels. 1

Classification and Mechanism of Action

Pregabalin belongs to a different class of medications than NSAIDs:

  • Pregabalin (Lyrica): An anticonvulsant medication that works by binding to calcium channels (α-δ subunits) in the brain and spinal cord, inhibiting the release of excitatory neurotransmitters involved in pain signaling 2

  • NSAIDs: Medications that inhibit cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) enzymes, which leads to their anti-inflammatory, analgesic, and antipyretic effects 2, 3

FDA-Approved Indications for Pregabalin

Pregabalin is FDA-approved for:

  • Diabetic neuropathy 2
  • Postherpetic neuralgia 2
  • Fibromyalgia 4
  • Certain types of seizures (as an anticonvulsant)

How NSAIDs Differ from Pregabalin

NSAIDs have distinct characteristics that differentiate them from pregabalin:

  • Mechanism: NSAIDs work by inhibiting COX enzymes, reducing prostaglandin synthesis and inflammation 2
  • Examples: Ibuprofen, naproxen, diclofenac, celecoxib 2
  • Side effects: Primarily gastrointestinal complications (ulcers, bleeding), cardiovascular risks, and renal effects 2, 3
  • Indications: Primarily used for conditions with inflammatory components such as arthritis, acute pain conditions, and musculoskeletal disorders 2

Clinical Implications of the Difference

Understanding that pregabalin is not an NSAID has important clinical implications:

  1. Different side effect profiles:

    • Pregabalin: Common side effects include somnolence, dizziness, weight gain, and peripheral edema 4
    • NSAIDs: Common side effects include gastrointestinal bleeding, cardiovascular events, and renal dysfunction 2, 3
  2. Different monitoring requirements:

    • Pregabalin: Monitor for depression, suicidal thoughts, and cognitive dysfunction 1
    • NSAIDs: Monitor for gastrointestinal symptoms, cardiovascular events, renal function, and drug interactions 3
  3. Different drug interactions:

    • Pregabalin may increase sedation when combined with CNS depressants 1
    • NSAIDs may interact with anticoagulants, ACE inhibitors, ARBs, and diuretics 3

Appropriate Use of Pregabalin

Pregabalin is specifically recommended for:

  • Neuropathic pain conditions 2, 5
  • Fibromyalgia 2, 4
  • As an adjunct for patients who have had insufficient response to other treatments 2

Unlike NSAIDs, pregabalin does not have anti-inflammatory properties and would not be appropriate for conditions where inflammation is the primary pain generator.

Common Pitfalls to Avoid

  1. Mistaking drug classes: Don't confuse anticonvulsants like pregabalin with NSAIDs, as they have different mechanisms, indications, and side effect profiles

  2. Inappropriate substitution: Pregabalin should not be substituted for NSAIDs when anti-inflammatory effects are needed

  3. Overlooking potential benefits: In conditions like fibromyalgia, pregabalin may be more effective than NSAIDs, which have limited evidence for effectiveness in this condition 2

  4. Missing potential synergies: For some pain conditions, pregabalin may be used in combination with other medications, including NSAIDs, for synergistic effects 6

In summary, pregabalin (Lyrica) is an anticonvulsant medication that works through calcium channel modulation, not an NSAID, and has distinct therapeutic applications primarily for neuropathic pain and fibromyalgia.

References

Research

Pregabalin for the management of fibromyalgia syndrome.

Journal of pain research, 2010

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Monitoring and Management of Patients on Long-term Nonsteroidal Anti-Inflammatory Drug (NSAID) Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pregabalin for pain in fibromyalgia in adults.

The Cochrane database of systematic reviews, 2016

Research

Pregabalin for neuropathic pain in adults.

The Cochrane database of systematic reviews, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.